EVENTIDE ASSET MANAGEMENT LLC 13D and 13G filings for Prometheus Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 1:58 pm Sale | 2022-12-31 | 13G | Prometheus Biosciences, Inc. RXDX | EVENTIDE ASSET MANAGEMENT LLC | 1,032,938 2.200% | -2,709,569 (-72.40%) | Filing |
| 2022-02-14 11:35 am Purchase | 2021-12-31 | 13G | Prometheus Biosciences, Inc. RXDX | EVENTIDE ASSET MANAGEMENT LLC | 3,742,507 9.600% | 3,742,507 (New Position) | Filing |